Skip to main content
Clinical Trials/NCT04834245
NCT04834245
Completed
Not Applicable

Evaluation of Diabetic Foot Wound Healing Using Hydrogel/Nano Silver-based Dressing vs. Traditional Dressing: A Prospective Randomized Control Study

Magda Bayoumi1 site in 1 country30 target enrollmentJanuary 3, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus
Sponsor
Magda Bayoumi
Enrollment
30
Locations
1
Primary Endpoint
the percentage of a reduction rate of the diabetic foot ulcer after intervention
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Background: The wound dressings perform a crucial role in the cutaneous wounds' management due to their ability to protect wounds and promote dermal and epidermal tissue regeneration. Objective: the aim of the present study to evaluate the effectiveness of using hydrogel/nano silver-based dressing vs. traditional dressing on diabetic foot wound healing.

Approach: Sixty patients with type-2 diabetes hospitalized for diabetic foot wound treatment were recruited from selected Surgical departments at Kasr Al-Aini university hospital.

Detailed Description

Data Collection: The patients of group-I wounds were cleaned using normal saline; then, the wounds were closed firmly with hyderogel\\nano silver dressing. The dressing was changed every two days according to dressing manufacture instruction. When the dressing was opened after three days, the wound was assessed for granulation tissue, wound, and discharge size. The patients of group II wounds were dresses using a traditional method, cleaned by normal saline, use of betadine antiseptic; then they were secured with clean linen gauze. The dressing was changed once daily. The wound healing process of the two groups was then assessed for three consecutive weeks.

Registry
clinicaltrials.gov
Start Date
January 3, 2019
End Date
December 30, 2019
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Magda Bayoumi
Responsible Party
Sponsor Investigator
Principal Investigator

Magda Bayoumi

Lecturer

Beni-Suef University

Eligibility Criteria

Inclusion Criteria

  • Diabetes Type I and Type II patient with diabetic foot ulcer age ranged 35-55 years old Willing to participate

Exclusion Criteria

  • unwilling to participate.

Outcomes

Primary Outcomes

the percentage of a reduction rate of the diabetic foot ulcer after intervention

Time Frame: 3 Weeks

assess of diabetic foot ulcers size "sq mm"

Study Sites (1)

Loading locations...

Similar Trials